NEW YORK, Jan. 11 2016 /PRNewswire/ -- Laidlaw & Company (LTD) ("the Company") announces today the Company's sponsorship of the Biotech Showcase 2016 being held in San Francisco, CA January 11-13th, 2016 (http://www.ebdgroup.com/bts/sponsors/index.php). The Company is honored to be one of the leading sponsors and considers the Biotech Showcase a premier event for the healthcare community.
About Laidlaw & Company, LTD.
Laidlaw & Company is a full service investment bank and securities brokerage firm with offices in New York, London, San Francisco and select additional locations. Its corporate finance efforts are focused on the healthcare, natural resource and social commerce sectors. In addition to capital raising, its investment banking arm provides M&A, restructuring and other financial advisory services for public and private small cap and middle market clients across a broad cross-section of industry sectors. Its brokerage arm provides wealth management services for domestic and international high-net-worth and institutional clients. Laidlaw is authorized by the FCA in the United Kingdom, and is regulated by FINRA in the United States.
About the Biotech Showcase™ 2016 Conference
Co-produced by Demy-Colton Life Science Advisors and EBD Group, Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies an opportunity to present to, and meet with, investors and pharmaceutical executives during the course of one of the industry's largest annual healthcare investor conferences. Now in its eighth year, Biotech Showcase is expected to attract upwards of 1,500 attendees.
Contact: Bryan Kobel, email@example.com
SOURCE Laidlaw & Co.